The global market size for blood pressure monitoring devices was estimated at USD 4.5 billion in 2022, and it is projected to expand at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. The key factor driving the growth of the market over the forecast period is the increasing incidences of hypertension due to changing lifestyles. According to the World Health Organization (WHO), around 1.28 billion people worldwide have hypertension, which is a leading cause of premature death globally. The demand for blood pressure (BP) monitors is high due to the growing geriatric population and the increasing risk of lifestyle-associated disorders among a wide population base.

Self-measured home blood pressure monitor is vital even before COVID-19, and it is even more important now to maintain blood pressure under control. The American Heart Association and the American Society of Hypertension, as well as the European Society of Hypertension and the National Institute for Health and Care Excellence (NICE), strongly advise monitoring blood pressure twice daily for seven consecutive days, preferably in the morning and evening, with two measurements taken 1–2 minutes apart on each occasion. This is fueling the demand for BP monitors. Government initiatives, such as public BP monitoring programs, are expected to propel further growth during the forecast period.

Advancements, such as mobile-based BP monitoring systems and digital sphygmomanometers, are anticipated to drive the demand. Improvements in devices for measuring BP, such as wearable & portable devices and mobiles, are gaining popularity owing to associated benefits, such as the wireless transmission of patient information and easy handling. New technologies, such as mHealth, which support treatment & medication compliance for patients in chronic disease management, are expected to fuel market growth. It helps in tracking the patient’s health information, medication schedule, and follow-up for the treatment. These associated advantages are some of the factors expected to propel growth.

The aneroid BP monitors/sphygmomanometers segment accounted for the largest share of more than 37.1% of the overall revenue in 2022 due to high demand. Technological advancements coupled with new product launches are expected to further fuel the demand for sphygmomanometers globally. The demand for blood pressure cuffs is expected to grow at a significant rate over the forecast period due to the increasing usage of BP monitors as a result of the growing incidence of high blood pressure.

The global blood pressure (BP) monitoring devices market has been categorized into hospitals, Ambulatory Surgical Centers (ASCs), and homecare based on end-uses. In 2022, the hospitals segment dominated the market and accounted for more than 65.4% of the revenue due to the large patient pool and the rising need for cost-effective, fast, and accurate diagnostic tools for better health outcomes.

The homecare segment is expected to exhibit the fastest CAGR of around 11.3% over the forecast period due to the availability of smart wearables that offer mobility and the cost efficiency of this alternate option for BP monitoring. Therefore, the inclination towards independent living is expected to propel the home healthcare market. Ambulatory BP Monitoring (ABPM) is used to measure out-of-office BP readings at specific time intervals, over a period of 24 hours, and offers a better way to predict long-term cardiovascular disease outcomes.

North America held the largest revenue share of more than 39.60% in 2022 due to its highly regulated & developed healthcare infrastructure. Increasing investments in the development of accurate and effective BP monitors is expected to contribute to the market growth of BP monitoring devices in the coming years. New product launches along with technological advancements are further expected to fuel the industry's growth. For instance, in February 2020, Hillrom announced the commercial launch of a new device, the Welch Allyn Spot Vital Signs 4400, which is an easy-to-use next-generation vital signs device used to improve hypertension detection in ambulatory & emergency department settings.

Asia-Pacific is expected to expand at the fastest CAGR over the forecast period owing to the presence of untapped opportunities, increasing investments by manufacturers, growing awareness levels, and rising incidences of hypertension. Supportive government initiatives for increasing awareness among people and a rapidly growing target disease population base are further contributing to the market growth in this region. For instance, in May 2018, The Indian Council of Medical Research (ICMR), in collaboration with the Public Health Foundation of India, launched the “May Measurement Month 2018” campaign to spread awareness about BP, which is the leading cause of mortality and morbidity in India.

*Photo Source: grandviewresearch